LANTHEUS HOLDINGS INC (LNTH) Stock Fundamental Analysis
NASDAQ:LNTH - Nasdaq - US5165441032 - Common Stock - Currency: USD
Overall LNTH gets a fundamental rating of 7 out of 10. We evaluated LNTH against 187 industry peers in the Health Care Equipment & Supplies industry. LNTH scores excellent points on both the profitability and health parts. This is a solid base for a good stock. LNTH may be a bit undervalued, certainly considering the very reasonable score on growth This makes LNTH very considerable for value and quality investing!
1. Profitability
1.1 Basic Checks
In the past year LNTH was profitable.
LNTH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LNTH reported negative net income in multiple years.
In the past 5 years LNTH always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 12.37%, LNTH belongs to the top of the industry, outperforming 94.65% of the companies in the same industry.
LNTH has a better Return On Equity (21.85%) than 93.58% of its industry peers.
The Return On Invested Capital of LNTH (18.93%) is better than 97.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LNTH is significantly above the industry average of 7.89%.
The last Return On Invested Capital (18.93%) for LNTH is above the 3 year average (16.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.37% | ||
| ROE | 21.85% | ||
| ROIC | 18.93% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
1.3 Margins
LNTH has a Profit Margin of 16.55%. This is amongst the best in the industry. LNTH outperforms 93.58% of its industry peers.
In the last couple of years the Profit Margin of LNTH has grown nicely.
LNTH has a better Operating Margin (29.30%) than 98.40% of its industry peers.
In the last couple of years the Operating Margin of LNTH has grown nicely.
LNTH's Gross Margin of 64.04% is fine compared to the rest of the industry. LNTH outperforms 66.31% of its industry peers.
In the last couple of years the Gross Margin of LNTH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.3% | ||
| PM (TTM) | 16.55% | ||
| GM | 64.04% |
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
2. Health
2.1 Basic Checks
LNTH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for LNTH remains at a similar level compared to 1 year ago.
The number of shares outstanding for LNTH has been increased compared to 5 years ago.
LNTH has a better debt/assets ratio than last year.
2.2 Solvency
LNTH has an Altman-Z score of 6.30. This indicates that LNTH is financially healthy and has little risk of bankruptcy at the moment.
LNTH has a Altman-Z score of 6.30. This is amongst the best in the industry. LNTH outperforms 83.96% of its industry peers.
The Debt to FCF ratio of LNTH is 1.20, which is an excellent value as it means it would take LNTH, only 1.20 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.20, LNTH belongs to the top of the industry, outperforming 90.37% of the companies in the same industry.
A Debt/Equity ratio of 0.49 indicates that LNTH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.49, LNTH is in line with its industry, outperforming 41.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 1.2 | ||
| Altman-Z | 6.3 |
ROIC/WACC2.25
WACC8.43%
2.3 Liquidity
A Current Ratio of 5.74 indicates that LNTH has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.74, LNTH belongs to the top of the industry, outperforming 81.28% of the companies in the same industry.
LNTH has a Quick Ratio of 5.46. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 5.46, LNTH belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.74 | ||
| Quick Ratio | 5.46 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 2.64% over the past year.
LNTH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.10% yearly.
The Revenue has grown by 12.53% in the past year. This is quite good.
The Revenue has been growing by 34.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2.64%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.47%
Revenue 1Y (TTM)12.53%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%0.75%
3.2 Future
Based on estimates for the next years, LNTH will show a small growth in Earnings Per Share. The EPS will grow by 7.20% on average per year.
LNTH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.69% yearly.
EPS Next Y-0.1%
EPS Next 2Y5.56%
EPS Next 3Y9.03%
EPS Next 5Y7.2%
Revenue Next Year3.48%
Revenue Next 2Y6.41%
Revenue Next 3Y8.41%
Revenue Next 5Y7.69%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.28, LNTH is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 91.44% of the companies listed in the same industry.
LNTH is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.76 indicates a reasonable valuation of LNTH.
Based on the Price/Forward Earnings ratio, LNTH is valued cheaper than 89.84% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, LNTH is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.28 | ||
| Fwd PE | 10.76 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LNTH is valued cheaper than 90.91% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LNTH is valued cheaply inside the industry as 95.19% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.89 | ||
| EV/EBITDA | 10.24 |
4.3 Compensation for Growth
LNTH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.29
EPS Next 2Y5.56%
EPS Next 3Y9.03%
5. Dividend
5.1 Amount
No dividends for LNTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
81.31
-2.52 (-3.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners115.61%
Inst Owner Change0.15%
Ins Owners1.3%
Ins Owner Change3.24%
Market Cap5.63B
Analysts82.11
Price Target131.89 (62.21%)
Short Float %13.52%
Short Ratio7.79
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.03%
Min EPS beat(2)-9.67%
Max EPS beat(2)1.61%
EPS beat(4)2
Avg EPS beat(4)-1.14%
Min EPS beat(4)-9.67%
Max EPS beat(4)7.07%
EPS beat(8)6
Avg EPS beat(8)5.62%
EPS beat(12)10
Avg EPS beat(12)11.67%
EPS beat(16)14
Avg EPS beat(16)27.27%
Revenue beat(2)1
Avg Revenue beat(2)-0.72%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)2.13%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.13%
Revenue beat(8)5
Avg Revenue beat(8)1%
Revenue beat(12)9
Avg Revenue beat(12)2.39%
Revenue beat(16)13
Avg Revenue beat(16)4.62%
PT rev (1m)0%
PT rev (3m)-3.78%
EPS NQ rev (1m)-0.74%
EPS NQ rev (3m)-2.96%
EPS NY rev (1m)-0.72%
EPS NY rev (3m)-5.6%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-1.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.28 | ||
| Fwd PE | 10.76 | ||
| P/S | 3.66 | ||
| P/FCF | 11.89 | ||
| P/OCF | 10.71 | ||
| P/B | 4.83 | ||
| P/tB | 5.93 | ||
| EV/EBITDA | 10.24 |
EPS(TTM)6.62
EY8.14%
EPS(NY)7.55
Fwd EY9.29%
FCF(TTM)6.84
FCFY8.41%
OCF(TTM)7.59
OCFY9.33%
SpS22.21
BVpS16.83
TBVpS13.72
PEG (NY)N/A
PEG (5Y)0.29
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.37% | ||
| ROE | 21.85% | ||
| ROCE | 24.91% | ||
| ROIC | 18.93% | ||
| ROICexc | 39.39% | ||
| ROICexgc | 52.34% | ||
| OM | 29.3% | ||
| PM (TTM) | 16.55% | ||
| GM | 64.04% | ||
| FCFM | 30.78% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
ROICexc(3y)32.43%
ROICexc(5y)N/A
ROICexgc(3y)46.23%
ROICexgc(5y)N/A
ROCE(3y)21.38%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y26.32%
ROICexc growth 3YN/A
ROICexc growth 5Y20.97%
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
F-Score8
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 1.2 | ||
| Debt/EBITDA | 1.1 | ||
| Cap/Depr | 82.91% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.34% | ||
| Profit Quality | 185.99% | ||
| Current Ratio | 5.74 | ||
| Quick Ratio | 5.46 | ||
| Altman-Z | 6.3 |
F-Score8
WACC8.43%
ROIC/WACC2.25
Cap/Depr(3y)104.83%
Cap/Depr(5y)78.74%
Cap/Sales(3y)4.75%
Cap/Sales(5y)4.15%
Profit Quality(3y)383.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.64%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.47%
EPS Next Y-0.1%
EPS Next 2Y5.56%
EPS Next 3Y9.03%
EPS Next 5Y7.2%
Revenue 1Y (TTM)12.53%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%0.75%
Revenue Next Year3.48%
Revenue Next 2Y6.41%
Revenue Next 3Y8.41%
Revenue Next 5Y7.69%
EBIT growth 1Y-5.08%
EBIT growth 3YN/A
EBIT growth 5Y54.05%
EBIT Next Year4.08%
EBIT Next 3Y11.97%
EBIT Next 5YN/A
FCF growth 1Y32.98%
FCF growth 3Y123.25%
FCF growth 5Y51.49%
OCF growth 1Y38.18%
OCF growth 3Y116.21%
OCF growth 5Y46.62%